Glaukos Analyst Ratings
BenzingaApr 11 19:36
Truist Securities: Reiterates Glaukos (GKOS.US) rating, adjusted from buy to buy rating, and adjusted target price from $110.00 to $110.00.
Zhitong FinanceApr 8 23:21
Glaukos Analyst Ratings
BenzingaApr 8 23:08
Glaukos Analyst Ratings
BenzingaApr 3 20:49
Glaukos (GKOS) Gets a Buy From Stifel Nicolaus
TipRanksApr 3 20:25
Analysts Offer Insights on Healthcare Companies: Eli Lilly & Co (LLY), Glaukos (GKOS) and Omnicell (OMCL)
TipRanksApr 3 17:40
Analysts Offer Insights on Healthcare Companies: Rhythm Pharmaceuticals (RYTM), Beam Therapeutics (BEAM) and Glaukos (GKOS)
TipRanksMar 26 18:20
Glaukos Analyst Ratings
BenzingaMar 23 02:49
Truist Financial Reaffirms Their Buy Rating on Glaukos (GKOS)
TipRanksMar 22 19:07
Glaukos Corporation: Hold Rating With Cautious Optimism Amidst IDose Launch and Reimbursement Uncertainties
TipRanksFeb 26 12:56
Piper Sandler Sticks to Its Buy Rating for Glaukos (GKOS)
TipRanksFeb 22 21:03
Needham Raises Price Target on Glaukos to $108 From $105, Maintains Buy Rating
MT NewswiresFeb 22 20:51
Buy Rating for Glaukos: A Comprehensive Analysis of Growth Drivers and Financial Stability
TipRanksFeb 22 20:27
Needham Maintains Buy on Glaukos, Raises Price Target to $108
BenzingaFeb 22 18:38
Glaukos Analyst Ratings
BenzingaFeb 22 18:37
Analysts Offer Insights on Healthcare Companies: GeneDx Holdings (WGS) and Glaukos (GKOS)
TipRanksFeb 22 18:30
Piper Sandler Gives a Buy Rating to Glaukos (GKOS)
TipRanksFeb 16 20:37
Analysts' Top Healthcare Picks: Ionis Pharmaceuticals (IONS), Glaukos (GKOS)
TipRanksFeb 16 18:29
Needham Reiterates Buy on Glaukos, Maintains $105 Price Target
BenzingaFeb 16 18:18
Glaukos Analyst Ratings
BenzingaFeb 16 18:17
No Data
No Data